Pharmaceuticals

China Type 1 Diabetes Drugs Market Research Report 2017

  • QYR1043788
  • 114 Pages
  • March 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Type 1 Diabetes Drugs

Revenue, means the sales value of Type 1 Diabetes Drugs

This report studies Type 1 Diabetes Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering

Novo Nordisk

Sanofi

Eli Lily

AstraZeneca

Astellas Pharma

Merck

Perle Biosciences

Pfizer

Merrion Pharmaceutical

Boehringer Ingelheim

XOMA

Osiris Therapeutics

GlaxoSmithKline

Generex Biotechnology

Gan & Lee Pharmaceuticals

Adocia

Baxalta

Tolerio

Market Segment by Regions (provinces), covering

South China

East China

Southwest China

Northeast China

North China

Central China

Northwest China

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into

Fast-Acting Insulin

Intermediate-Acting Insulin

Long-Acting Insulin

Other

Split by Application, this report focuses on consumption, market share and growth rate of Type 1 Diabetes Drugs in each application, can be divided into

Hospitals

Clinics

Table of Contents

China Type 1 Diabetes Drugs Market Research Report 2017

1 Type 1 Diabetes Drugs Market Overview

1.1 Product Overview and Scope of Type 1 Diabetes Drugs

1.2 Type 1 Diabetes Drugs Segment by Type

1.2.1 China Production Market Share of Type 1 Diabetes Drugs Type in 2015

1.2.2 Fast-Acting Insulin

1.2.3 Intermediate-Acting Insulin

1.2.4 Long-Acting Insulin

1.2.5 Other

1.3 Applications of Type 1 Diabetes Drugs

1.3.1 Type 1 Diabetes Drugs Consumption Market Share by Application in 2015

1.3.2 Hospitals

1.3.3 Clinics

1.4 China Market Size (Value) of Type 1 Diabetes Drugs (2012-2022)

1.5 China Type 1 Diabetes Drugs Status and Outlook

1.6 Government Policies

2 China Type 1 Diabetes Drugs Market Competition by Manufacturers

2.1 China Type 1 Diabetes Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)

2.2 China Type 1 Diabetes Drugs Revenue and Share by Manufacturers (2015 and 2016)

2.3 China Type 1 Diabetes Drugs Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Type 1 Diabetes Drugs Manufacturing Base Distribution, Sales Area, Product Type

2.5 Type 1 Diabetes Drugs Market Competitive Situation and Trends

2.5.1 Type 1 Diabetes Drugs Market Concentration Rate

2.5.2 Type 1 Diabetes Drugs Market Share of Top 3 and Top 5 Manufacturers

3 China Type 1 Diabetes Drugs Manufacturers Profiles/Analysis

3.1 Novo Nordisk

3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.1.2 Type 1 Diabetes Drugs Product Type, Application and Specification

3.1.2.1 Product A

3.1.2.2 Product B

3.1.3 Novo Nordisk Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.1.4 Main Business/Business Overview

3.2 Sanofi

3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.2.2 Type 1 Diabetes Drugs Product Type, Application and Specification

3.2.2.1 Product A

3.2.2.2 Product B

3.2.3 Sanofi Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.2.4 Main Business/Business Overview

3.3 Eli Lily

3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.3.2 Type 1 Diabetes Drugs Product Type, Application and Specification

3.3.2.1 Product A

3.3.2.2 Product B

3.3.3 Eli Lily Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.3.4 Main Business/Business Overview

3.4 AstraZeneca

3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.4.2 Type 1 Diabetes Drugs Product Type, Application and Specification

3.4.2.1 Product A

3.4.2.2 Product B

3.4.3 AstraZeneca Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.4.4 Main Business/Business Overview

3.5 Astellas Pharma

3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.5.2 Type 1 Diabetes Drugs Product Type, Application and Specification

3.5.2.1 Product A

3.5.2.2 Product B

3.5.3 Astellas Pharma Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.5.4 Main Business/Business Overview

3.6 Merck

3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.6.2 Type 1 Diabetes Drugs Product Type, Application and Specification

3.6.2.1 Product A

3.6.2.2 Product B

3.6.3 Merck Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.6.4 Main Business/Business Overview

3.7 Perle Biosciences

3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.7.2 Type 1 Diabetes Drugs Product Type, Application and Specification

3.7.2.1 Product A

3.7.2.2 Product B

3.7.3 Perle Biosciences Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.7.4 Main Business/Business Overview

3.8 Pfizer

3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.8.2 Type 1 Diabetes Drugs Product Type, Application and Specification

3.8.2.1 Product A

3.8.2.2 Product B

3.8.3 Pfizer Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.8.4 Main Business/Business Overview

3.9 Merrion Pharmaceutical

3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.9.2 Type 1 Diabetes Drugs Product Type, Application and Specification

3.9.2.1 Product A

3.9.2.2 Product B

3.9.3 Merrion Pharmaceutical Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.9.4 Main Business/Business Overview

3.10 Boehringer Ingelheim

3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.10.2 Type 1 Diabetes Drugs Product Type, Application and Specification

3.10.2.1 Product A

3.10.2.2 Product B

3.10.3 Boehringer Ingelheim Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.10.4 Main Business/Business Overview

3.11 XOMA

3.12 Osiris Therapeutics

3.13 GlaxoSmithKline

3.14 Generex Biotechnology

3.15 Gan & Lee Pharmaceuticals

3.16 Adocia

3.17 Baxalta

3.18 Tolerio

4 China Type 1 Diabetes Drugs Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)

4.1 China Type 1 Diabetes Drugs Capacity, Production and Growth (2012-2017)

4.2 China Type 1 Diabetes Drugs Revenue and Growth (2012-2017)

4.3 China Type 1 Diabetes Drugs Production, Consumption, Export and Import (2012-2017)

5 China Type 1 Diabetes Drugs Production, Revenue (Value), Price Trend by Type

5.1 China Type 1 Diabetes Drugs Production and Market Share by Type (2012-2017)

5.2 China Type 1 Diabetes Drugs Revenue and Market Share by Type (2012-2017)

5.3 China Type 1 Diabetes Drugs Price by Type (2012-2017)

5.4 China Type 1 Diabetes Drugs Production Growth by Type (2012-2017)

6 China Type 1 Diabetes Drugs Market Analysis by Application

6.1 China Type 1 Diabetes Drugs Consumption and Market Share by Application (2012-2017)

6.2 China Type 1 Diabetes Drugs Consumption Growth Rate by Application (2012-2017)

6.3 Market Drivers and Opportunities

6.3.1 Potential Application

6.3.2 Emerging Markets/Countries

7 ChinaType 1 Diabetes Drugs Market Analysis by Regions (Provinces)

7.1 China Type 1 Diabetes Drugs Production, Production Value and Price by Regions (Provinces)(2012-2017)

7.1.1 China Type 1 Diabetes Drugs Production and Market Share by Regions (Provinces)(2012-2017)

7.1.2 China Type 1 Diabetes Drugs Production Value and Market Share by Regions (Provinces)(2012-2017)

7.1.3 China Type 1 Diabetes Drugs Sales Price by Regions (Provinces)(2012-2017)

7.2 China Type 1 Diabetes Drugs Consumption by Regions (Provinces)(2012-2017)

7.3 China Type 1 Diabetes Drugs Production, Consumption, Export and Import (2012-2017)

8 Type 1 Diabetes Drugs Manufacturing Cost Analysis

8.1 Type 1 Diabetes Drugs Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Type 1 Diabetes Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Type 1 Diabetes Drugs Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Type 1 Diabetes Drugs Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 China Type 1 Diabetes Drugs Market Forecast (2017-2022)

12.1 China Type 1 Diabetes Drugs Capacity, Production, Revenue Forecast (2017-2022)

12.2 China Type 1 Diabetes Drugs Production, Import, Export and Consumption Forecast (2017-2022)

12.3 China Type 1 Diabetes Drugs Production Forecast by Type (2017-2022)

12.4 China Type 1 Diabetes Drugs Consumption Forecast by Application (2017-2022)

12.5 China Type 1 Diabetes Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

12.5.1 China Type 1 Diabetes Drugs Production Forecast by Regions (Provinces)(2017-2022)

12.5.2 China Type 1 Diabetes Drugs Consumption Forecast by Regions (Provinces)(2017-2022)

12.5.3 China Type 1 Diabetes Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

12.6 Type 1 Diabetes Drugs Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Type 1 Diabetes Drugs

Figure China Production Market Share of Type 1 Diabetes Drugs by Type in 2015

Figure Product Picture of Fast-Acting Insulin

Table Major Manufacturers of Fast-Acting Insulin

Figure Product Picture of Intermediate-Acting Insulin

Table Major Manufacturers of Intermediate-Acting Insulin

Figure Product Picture of Long-Acting Insulin

Table Major Manufacturers of Long-Acting Insulin

Figure Product Picture of Other

Table Major Manufacturers of Other

Table Type 1 Diabetes Drugs Consumption Market Share by Application in 2015

Figure Hospitals Examples

Figure Clinics Examples

Figure China Type 1 Diabetes Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Table China Type 1 Diabetes Drugs Capacity of Key Manufacturers (2015 and 2016)

Table China Type 1 Diabetes Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)

Figure China Type 1 Diabetes Drugs Capacity of Key Manufacturers in 2015

Figure China Type 1 Diabetes Drugs Capacity of Key Manufacturers in 2016

Table China Type 1 Diabetes Drugs Production of Key Manufacturers (2015 and 2016)

Table China Type 1 Diabetes Drugs Production Share by Manufacturers (2015 and 2016)

Figure 2015 Type 1 Diabetes Drugs Production Share by Manufacturers

Figure 2016 Type 1 Diabetes Drugs Production Share by Manufacturers

Table China Type 1 Diabetes Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)

Table China Type 1 Diabetes Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 China Type 1 Diabetes Drugs Revenue Share by Manufacturers

Table 2016 China Type 1 Diabetes Drugs Revenue Share by Manufacturers

Table China Market Type 1 Diabetes Drugs Average Price of Key Manufacturers (2015 and 2016)

Figure China Market Type 1 Diabetes Drugs Average Price of Key Manufacturers in 2015

Table Manufacturers Type 1 Diabetes Drugs Manufacturing Base Distribution and Sales Area

Table Manufacturers Type 1 Diabetes Drugs Product Type

Figure Type 1 Diabetes Drugs Market Share of Top 3 Manufacturers

Figure Type 1 Diabetes Drugs Market Share of Top 5 Manufacturers

Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novo Nordisk Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Novo Nordisk Type 1 Diabetes Drugs Market Share (2012-2017)

Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Sanofi Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Sanofi Type 1 Diabetes Drugs Market Share (2012-2017)

Table Eli Lily Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Eli Lily Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Eli Lily Type 1 Diabetes Drugs Market Share (2012-2017)

Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table AstraZeneca Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure AstraZeneca Type 1 Diabetes Drugs Market Share (2012-2017)

Table Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Astellas Pharma Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Astellas Pharma Type 1 Diabetes Drugs Market Share (2012-2017)

Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Merck Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Merck Type 1 Diabetes Drugs Market Share (2012-2017)

Table Perle Biosciences Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Perle Biosciences Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Perle Biosciences Type 1 Diabetes Drugs Market Share (2012-2017)

Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Pfizer Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Pfizer Type 1 Diabetes Drugs Market Share (2012-2017)

Table Merrion Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Merrion Pharmaceutical Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Merrion Pharmaceutical Type 1 Diabetes Drugs Market Share (2012-2017)

Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Boehringer Ingelheim Type 1 Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Boehringer Ingelheim Type 1 Diabetes Drugs Market Share (2012-2017)

Table XOMA Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Osiris Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Generex Biotechnology Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Gan & Lee Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Adocia Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Baxalta Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Tolerio Basic Information, Manufacturing Base, Sales Area and Its Competitors

Figure China Type 1 Diabetes Drugs Capacity, Production and Growth (2012-2017)

Figure China Type 1 Diabetes Drugs Revenue (Million USD) and Growth (2012-2017)

Table China Type 1 Diabetes Drugs Production, Consumption, Export and Import (2012-2017)

Table China Type 1 Diabetes Drugs Production by Type (2012-2017)

Table China Type 1 Diabetes Drugs Production Share by Type (2012-2017)

Figure Production Market Share of Type 1 Diabetes Drugs by Type (2012-2017)

Figure 2015 Production Market Share of Type 1 Diabetes Drugs by Type

Table China Type 1 Diabetes Drugs Revenue by Type (2012-2017)

Table China Type 1 Diabetes Drugs Revenue Share by Type (2012-2017)

Figure Production Revenue Share of Type 1 Diabetes Drugs by Type (2012-2017)

Figure 2015 Revenue Market Share of Type 1 Diabetes Drugs by Type

Table China Type 1 Diabetes Drugs Price by Type (2012-2017)

Figure China Type 1 Diabetes Drugs Production Growth by Type (2012-2017)

Table China Type 1 Diabetes Drugs Consumption by Application (2012-2017)

Table China Type 1 Diabetes Drugs Consumption Market Share by Application (2012-2017)

Figure China Type 1 Diabetes Drugs Consumption Market Share by Application in 2015

Table China Type 1 Diabetes Drugs Consumption Growth Rate by Application (2012-2017)

Figure China Type 1 Diabetes Drugs Consumption Growth Rate by Application (2012-2017)

Table China Type 1 Diabetes Drugs Production by Regions (Provinces)(2012-2017)

Table China Type 1 Diabetes Drugs Production Market Share by Regions (Provinces)(2012-2017)

Table China Type 1 Diabetes Drugs Production Value by Regions (Provinces)(2012-2017)

Table China Type 1 Diabetes Drugs Production Value Market Share by Regions (Provinces)(2012-2017)

Table China Type 1 Diabetes Drugs Sales Price by Regions (Provinces)(2012-2017)

Table China Type 1 Diabetes Drugs Consumption by Regions (Provinces)(2012-2017)

Table China Type 1 Diabetes Drugs Consumption Market Share by Regions (Provinces)(2012-2017)

Table China Type 1 Diabetes Drugs Production, Consumption, Export and Import (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Type 1 Diabetes Drugs

Figure Manufacturing Process Analysis of Type 1 Diabetes Drugs

Figure Type 1 Diabetes Drugs Industrial Chain Analysis

Table Raw Materials Sources of Type 1 Diabetes Drugs Major Manufacturers in 2015

Table Major Buyers of Type 1 Diabetes Drugs

Table Distributors/Traders List

Figure China Type 1 Diabetes Drugs Capacity, Production and Growth Rate Forecast (2017-2022)

Figure China Type 1 Diabetes Drugs Revenue and Growth Rate Forecast (2017-2022)

Table China Type 1 Diabetes Drugs Production, Import, Export and Consumption Forecast (2017-2022)

Table China Type 1 Diabetes Drugs Production Forecast by Type (2017-2022)

Table China Type 1 Diabetes Drugs Consumption Forecast by Application (2017-2022)

Table China Type 1 Diabetes Drugs Production Forecast by Regions (Provinces)(2017-2022)

Table China Type 1 Diabetes Drugs Consumption Forecast by Regions (Provinces)(2017-2022)

Table China Type 1 Diabetes Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370